A new study finds long-term evidence that actively monitoring localized prostate cancer, rather than taking action can be a safe option. British researchers studied 1600 patients with prostate cancer in the UK, who were randomly assigned surgery, radiation, or active monitoring. In all three groups, after 15 years, this survival rate was very high. 97%, regardless of the treatment option. Lead study author, doctor Freddie hamdi at the University of Oxford, says this is great news for men diagnosed with localized prostate cancer, and they shouldn't panic or rush a treatment decision. Others note those who can hold off on treatment can avoid the possible side effects of sexual difficulties or incontinence. I'm Jackie Quinn